WHO Guidelines for pharmacological management of pandemic influenza A(H1N1) 2009 and other influenza viruses: part II review of evidence
This revised guidance is published in two parts. Part II documents the procedures followed in developing this guidance, together with a review of evidence and other new information on the pharmacological agents considered....
Pandémies, Sous-type H1N1 du virus de la grippe A, Grippe humaine/traitement médicamenteux, Infections à virus à ARN/traitement médicamenteux, Oséltamivir/administration et posologie, Zanamivir/administration et posologie, Amantadine/administration et posologie, Rimantadine/administration et posologie, Ribavirine/administration et posologie, Antiviraux/administration et posologie